Cargando…
Optimizing Distribution of Pandemic Influenza Antiviral Drugs
We provide a data-driven method for optimizing pharmacy-based distribution of antiviral drugs during an influenza pandemic in terms of overall access for a target population and apply it to the state of Texas, USA. We found that during the 2009 influenza pandemic, the Texas Department of State Healt...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4313645/ https://www.ncbi.nlm.nih.gov/pubmed/25625858 http://dx.doi.org/10.3201/eid2102.141024 |
_version_ | 1782355250976391168 |
---|---|
author | Singh, Bismark Huang, Hsin-Chan Morton, David P. Johnson, Gregory P. Gutfraind, Alexander Galvani, Alison P. Clements, Bruce Meyers, Lauren A. |
author_facet | Singh, Bismark Huang, Hsin-Chan Morton, David P. Johnson, Gregory P. Gutfraind, Alexander Galvani, Alison P. Clements, Bruce Meyers, Lauren A. |
author_sort | Singh, Bismark |
collection | PubMed |
description | We provide a data-driven method for optimizing pharmacy-based distribution of antiviral drugs during an influenza pandemic in terms of overall access for a target population and apply it to the state of Texas, USA. We found that during the 2009 influenza pandemic, the Texas Department of State Health Services achieved an estimated statewide access of 88% (proportion of population willing to travel to the nearest dispensing point). However, access reached only 34.5% of US postal code (ZIP code) areas containing <1,000 underinsured persons. Optimized distribution networks increased expected access to 91% overall and 60% in hard-to-reach regions, and 2 or 3 major pharmacy chains achieved near maximal coverage in well-populated areas. Independent pharmacies were essential for reaching ZIP code areas containing <1,000 underinsured persons. This model was developed during a collaboration between academic researchers and public health officials and is available as a decision support tool for Texas Department of State Health Services at a Web-based interface. |
format | Online Article Text |
id | pubmed-4313645 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-43136452015-02-04 Optimizing Distribution of Pandemic Influenza Antiviral Drugs Singh, Bismark Huang, Hsin-Chan Morton, David P. Johnson, Gregory P. Gutfraind, Alexander Galvani, Alison P. Clements, Bruce Meyers, Lauren A. Emerg Infect Dis Research We provide a data-driven method for optimizing pharmacy-based distribution of antiviral drugs during an influenza pandemic in terms of overall access for a target population and apply it to the state of Texas, USA. We found that during the 2009 influenza pandemic, the Texas Department of State Health Services achieved an estimated statewide access of 88% (proportion of population willing to travel to the nearest dispensing point). However, access reached only 34.5% of US postal code (ZIP code) areas containing <1,000 underinsured persons. Optimized distribution networks increased expected access to 91% overall and 60% in hard-to-reach regions, and 2 or 3 major pharmacy chains achieved near maximal coverage in well-populated areas. Independent pharmacies were essential for reaching ZIP code areas containing <1,000 underinsured persons. This model was developed during a collaboration between academic researchers and public health officials and is available as a decision support tool for Texas Department of State Health Services at a Web-based interface. Centers for Disease Control and Prevention 2015-02 /pmc/articles/PMC4313645/ /pubmed/25625858 http://dx.doi.org/10.3201/eid2102.141024 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Research Singh, Bismark Huang, Hsin-Chan Morton, David P. Johnson, Gregory P. Gutfraind, Alexander Galvani, Alison P. Clements, Bruce Meyers, Lauren A. Optimizing Distribution of Pandemic Influenza Antiviral Drugs |
title | Optimizing Distribution of Pandemic Influenza Antiviral Drugs |
title_full | Optimizing Distribution of Pandemic Influenza Antiviral Drugs |
title_fullStr | Optimizing Distribution of Pandemic Influenza Antiviral Drugs |
title_full_unstemmed | Optimizing Distribution of Pandemic Influenza Antiviral Drugs |
title_short | Optimizing Distribution of Pandemic Influenza Antiviral Drugs |
title_sort | optimizing distribution of pandemic influenza antiviral drugs |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4313645/ https://www.ncbi.nlm.nih.gov/pubmed/25625858 http://dx.doi.org/10.3201/eid2102.141024 |
work_keys_str_mv | AT singhbismark optimizingdistributionofpandemicinfluenzaantiviraldrugs AT huanghsinchan optimizingdistributionofpandemicinfluenzaantiviraldrugs AT mortondavidp optimizingdistributionofpandemicinfluenzaantiviraldrugs AT johnsongregoryp optimizingdistributionofpandemicinfluenzaantiviraldrugs AT gutfraindalexander optimizingdistributionofpandemicinfluenzaantiviraldrugs AT galvanialisonp optimizingdistributionofpandemicinfluenzaantiviraldrugs AT clementsbruce optimizingdistributionofpandemicinfluenzaantiviraldrugs AT meyerslaurena optimizingdistributionofpandemicinfluenzaantiviraldrugs |